iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR)
Category Sector Equity Healthcare
This ETF can be held in an Investment ISA, SIPP and Investment Account
Sell
539.75p
Buy
540.50p
-13.625p (-2.46%)
Prices updated at 07 May 2025, 16:15 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Investment objective
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the STOXX Global Breakthrough Healthcare Index.
Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website which details further information in relation to sustainability disclosure requirements for retail clients.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk profile
- Management
Portfolio as of 02/05/2025
Asset allocation
Show long & short position
Geographical breakdown
Continent or country allocation (%)
Market classification (%)
Stock style
Large value
18.68%
% Weight
Value
Core
Growth
Large
19
8
17
Medium
3
7
13
Small
4
15
14
Valuation
iShares Healthcare Innovation UCITS ETF USD (Acc)
Sector Equity Healthcare
17.90
3.25
3.29
12.45
Growth rate
iShares Healthcare Innovation UCITS ETF USD (Acc)
Sector Equity Healthcare
9.98%
1.05%
-2.18%
Top 10 holdings
Security name | Sector | Country | % of assets | |
---|---|---|---|---|
1 | argenx SE | - | China | 2.78 |
2 | Gilead Sciences Inc | - | United States | 2.56 |
3 | Natera Inc | - | United States | 2.23 |
4 | UCB SA | - | Belgium | 2.18 |
5 | Boston Scientific Corp | - | United States | 2.18 |
6 | Insulet Corp | - | United States | 2.14 |
7 | Lonza Group Ltd | - | Switzerland | 2.11 |
8 | Intuitive Surgical Inc | - | United States | 2.03 |
9 | Abbott Laboratories | - | United States | 2.01 |
10 | Samsung BioLogics Co Ltd | - | South Korea | 1.96 |
Assets in top 10 holdings %
22.20%
Total no. of equity holdings
186.00
Total no. of bond holdings
-
Stock sectors
iShares Healthcare Innovation UCITS ETF USD (Acc)
Sector Equity Healthcare
0.74%
Basic materials
Con cyclical
Financial svs
Real estate
1.86%
Comm services
Energy
Industrials
Technology
97.41%
Con defensive
Healthcare
Utilities